Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H19NOS.ClH |
Molecular Weight | 333.876 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CNCC[C@H](OC1=C2C=CC=CC2=CC=C1)C3=CC=CS3
InChI
InChIKey=BFFSMCNJSOPUAY-LMOVPXPDSA-N
InChI=1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C18H19NOS |
Molecular Weight | 297.415 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:41:44 UTC 2023
by
admin
on
Fri Dec 15 15:41:44 UTC 2023
|
Record UNII |
9044SC542W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
DULOXETINE MYLAN (AUTHORIZED: DEPRESSIVE DISORDER, MAJOR)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ARICLAIM (AUTHORIZED: DIABETIC NEUROPATHIES)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DULOXETINE MYLAN (AUTHORIZED: DIABETIC NEUROPATHIES)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CYMBALTA (AUTHORIZED: DEPRESSIVE DISORDER, MAJOR)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
XERISTAR (AUTHORIZED: DEPRESSIVE DISORDER, MAJOR)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DULOXETINE BOEHRINGER INGELHEIM (WITHDRAWN: DIABETIC NEUROPATHIES)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CYMBALTA (AUTHORIZED: DIABETIC NEUROPATHIES)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DULOXETINE LILLY (AUTHORIZED: DIABETIC NEUROPATHIES)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
XERISTAR (AUTHORIZED: DIABETIC NEUROPATHIES)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
YENTREVE (AUTHORIZED: URINARY INCONTINENCE, STRESS)
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
EE-18
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
C65496
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
31526
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
9044SC542W
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
100000093366
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
CHEMBL1175
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
DTXSID9046443
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
SUB20026
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
60834
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
759112
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
136434-34-9
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
9044SC542W
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
1229817
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
476250
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB00476
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | |||
|
m4782
Created by
admin on Fri Dec 15 15:41:44 UTC 2023 , Edited by admin on Fri Dec 15 15:41:44 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
PARENT -> SALT/SOLVATE |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
ASSAY (HPLC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|